Biohaven Pharmaceuticals (BHVN) Gains Following Sales Surge for Migraine Drug NURTEC ODT

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. AAPL
6. RTB
7. ONON
8. AZN
9. SPCX
10. TRMD

Go back to Biohaven Pharmaceuticals (BHVN) Gains Following Sales Surge for Migraine Drug NURTEC ODT
(NYSE: BHVN) Delayed: 13.62 -0.27 (1.94%)
Previous Close $13.89    52 Week High $ 
Open $14.07    52 Week Low $ 
Day High $14.37    P/E N/A 
Day Low $13.46    EPS $ 
Volume 6,431,852